181 related articles for article (PubMed ID: 32801750)
1. Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics.
Pan G; Ma Y; Suo J; Li W; Zhang Y; Qin S; Jiao Y; Zhang S; Li S; Kong Y; Du Y; Gao S; Wang D
Onco Targets Ther; 2020; 13():7199-7211. PubMed ID: 32801750
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
3. Across-polarity quantification method for broad metabolome coverage based on consecutive nanoconfined liquid phase nanoextraction technology: Application in discovering the plasma potential biomarkers of different types of cancer.
Yu C; Zhang Q; Zou Y; Liu R; Zhao J; Bi K; Li D; Li Q
Anal Chim Acta; 2021 Jul; 1167():338577. PubMed ID: 34049631
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.
Chen JL; Tang HQ; Hu JD; Fan J; Hong J; Gu JZ
World J Gastroenterol; 2010 Dec; 16(46):5874-80. PubMed ID: 21155010
[TBL] [Abstract][Full Text] [Related]
6. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.
Hu JD; Tang HQ; Zhang Q; Fan J; Hong J; Gu JZ; Chen JL
World J Gastroenterol; 2011 Feb; 17(6):727-34. PubMed ID: 21390142
[TBL] [Abstract][Full Text] [Related]
7. Application of global metabolomic profiling of synovial fluid for osteoarthritis biomarkers.
Carlson AK; Rawle RA; Adams E; Greenwood MC; Bothner B; June RK
Biochem Biophys Res Commun; 2018 May; 499(2):182-188. PubMed ID: 29551687
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics.
Özer Ö; Nemutlu E; Reçber T; Eylem CC; Aktas BY; Kır S; Kars A; Aksoy S
Eur J Mass Spectrom (Chichester); 2022 Feb; 28(1-2):56-64. PubMed ID: 35422172
[No Abstract] [Full Text] [Related]
9. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
10. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolomics and lipidomics reveal potential novel biomarkers in early gastric cancer: An explorative study.
Wang F; Pang R; Zhao X; Zhou B; Tian Y; Ma Y; Rong L
Int J Biol Markers; 2024 Jun; ():3936155241258780. PubMed ID: 38859802
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
13. Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers.
Carlson AK; Rawle RA; Wallace CW; Adams E; Greenwood MC; Bothner B; June RK
Clin Exp Rheumatol; 2019; 37(3):393-399. PubMed ID: 30620276
[TBL] [Abstract][Full Text] [Related]
14. A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia.
Okamoto N; Ikenouchi A; Watanabe K; Igata R; Fujii R; Yoshimura R
Front Psychiatry; 2021; 12():763547. PubMed ID: 34975570
[No Abstract] [Full Text] [Related]
15. [A serum metabolomics study of gastric cancer based on pseudotargeted liquid chromatography-mass spectrometry approach].
Yang T; Luo P; Li Y; Hua R; Yin P; Xu G
Se Pu; 2014 Feb; 32(2):126-32. PubMed ID: 24822445
[TBL] [Abstract][Full Text] [Related]
16. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
17. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve.
Yin J; Xie J; Guo X; Ju L; Li Y; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():428-435. PubMed ID: 27649503
[TBL] [Abstract][Full Text] [Related]
18. Discovery and validation of peritoneal endometriosis biomarkers in peritoneal fluid and serum.
Loy SL; Zhou J; Cui L; Tan TY; Ee TX; Chern BSM; Chan JKY; Lee YH
Reprod Biomed Online; 2021 Oct; 43(4):727-737. PubMed ID: 34446375
[TBL] [Abstract][Full Text] [Related]
19. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]